Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
Biochemical and Biophysical Research Communications|February 28, 1989
The A1 adenosine receptor antagonist 1,3, dipropyl-8-cyclopentylxanthine (DPCPX) displays adenosine agonist properties in the FRTL5 thyroid cell lineA G Frauman, A C MosesEndocrinology and Metabolism Clinics of North America|September 1, 1990
Oncogenes and growth factors in thyroid carcinogenesisA G Frauman, A C MosesEndocrinology|May 1, 1989
The binding characteristics and biological effects in FRTL5 cells of placental protein-12, an insulin-like growth factor-binding protein purified from human amniotic fluidA G Frauman, S Tsuzaki, A C MosesEndocrinology|November 1, 1989
Adenosine has divergent effects on deoxyribonucleic acid synthesis in FRTL5 cells: inhibition of thyrotropin-stimulated and potentiation of insulin-like growth factor-I-stimulated thymidine incorporationA C Moses, D Tramontano, B M Veneziani, et al.Adverse Drug Reactions and Toxicological Reviews|November 1, 1996
An overview of the adverse reactions to adrenal corticosteroidsA G FraumanThe Journal of Pathology|August 10, 1999
Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour gradeT Bouras, A G FraumanThe Journal of Clinical Endocrinology and Metabolism|May 10, 2001
Extrathyroidal manifestations of Graves' disease: the thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissuesB E Busuttil, A G FraumanDiabetes Research and Clinical Practice|July 1, 1987
Effects of intranasal insulin in non-obese type II diabeticsA G Frauman, G Jerums, W J LouisBiochemical and Biophysical Research Communications|January 23, 1997
The full length and splice variant thyrotropin receptor is expressed exclusively in skeletal muscle of extraocular origin: a link to the pathogenesis of Graves' ophthalmopathyB J Major, A Cures, A G FraumanPageof 13